Skip to content
PatientMatchFind trials

Screener

Eligibility screening

Highly Selective CDK7 Inhibitor Q901 in Advanced Solid Tumors

Sponsored by Qurient Co., Ltd.Study detailsClinicalTrials.gov

7 US sites in AZ, CA, FL, IL +3

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.